BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19797082)

  • 1. Structural basis of alternative DNA recognition by Maf transcription factors.
    Kurokawa H; Motohashi H; Sueno S; Kimura M; Takagawa H; Kanno Y; Yamamoto M; Tanaka T
    Mol Cell Biol; 2009 Dec; 29(23):6232-44. PubMed ID: 19797082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants for small Maf protein control of platelet production.
    Motohashi H; Fujita R; Takayama M; Inoue A; Katsuoka F; Bresnick EH; Yamamoto M
    Mol Cell Biol; 2011 Jan; 31(1):151-62. PubMed ID: 20974807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the DNA-binding domain of MafG.
    Kusunoki H; Motohashi H; Katsuoka F; Morohashi A; Yamamoto M; Tanaka T
    Nat Struct Biol; 2002 Apr; 9(4):252-6. PubMed ID: 11875518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements.
    Yamamoto T; Kyo M; Kamiya T; Tanaka T; Engel JD; Motohashi H; Yamamoto M
    Genes Cells; 2006 Jun; 11(6):575-91. PubMed ID: 16716189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer.
    Kimura M; Yamamoto T; Zhang J; Itoh K; Kyo M; Kamiya T; Aburatani H; Katsuoka F; Kurokawa H; Tanaka T; Motohashi H; Yamamoto M
    J Biol Chem; 2007 Nov; 282(46):33681-33690. PubMed ID: 17875642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel DNA binding mechanism for maf basic region-leucine zipper factors inferred from a MafA-DNA complex structure and binding specificities.
    Lu X; Guanga GP; Wan C; Rose RB
    Biochemistry; 2012 Dec; 51(48):9706-17. PubMed ID: 23148532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif.
    Toki T; Itoh J; Kitazawa J; Arai K; Hatakeyama K; Akasaka J; Igarashi K; Nomura N; Yokoyama M; Yamamoto M; Ito E
    Oncogene; 1997 Apr; 14(16):1901-10. PubMed ID: 9150357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection.
    Otsuki A; Suzuki M; Katsuoka F; Tsuchida K; Suda H; Morita M; Shimizu R; Yamamoto M
    Free Radic Biol Med; 2016 Feb; 91():45-57. PubMed ID: 26677805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Maf proteins (MafF, MafG, MafK): History, structure and function.
    Katsuoka F; Yamamoto M
    Gene; 2016 Jul; 586(2):197-205. PubMed ID: 27058431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA sequence-dependent folding determines the divergence in binding specificities between Maf and other bZIP proteins.
    Dlakić M; Grinberg AV; Leonard DA; Kerppola TK
    EMBO J; 2001 Feb; 20(4):828-40. PubMed ID: 11179227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor.
    Kataoka K; Igarashi K; Itoh K; Fujiwara KT; Noda M; Yamamoto M; Nishizawa M
    Mol Cell Biol; 1995 Apr; 15(4):2180-90. PubMed ID: 7891713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins.
    Kerppola TK; Curran T
    Oncogene; 1994 Nov; 9(11):3149-58. PubMed ID: 7936637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MafG sumoylation is required for active transcriptional repression.
    Motohashi H; Katsuoka F; Miyoshi C; Uchimura Y; Saitoh H; Francastel C; Engel JD; Yamamoto M
    Mol Cell Biol; 2006 Jun; 26(12):4652-63. PubMed ID: 16738329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5'-AT-rich half-site of Maf recognition element: a functional target for bZIP transcription factor Maf.
    Yoshida T; Ohkumo T; Ishibashi S; Yasuda K
    Nucleic Acids Res; 2005; 33(11):3465-78. PubMed ID: 15972792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic control of half-site spacing preferences by the cyclic AMP response element-binding protein CREB.
    Montclare JK; Sloan LS; Schepartz A
    Nucleic Acids Res; 2001 Aug; 29(16):3311-9. PubMed ID: 11504868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and Specific Functional Evaluation of the Nrf2 and MafG Heterodimer by Introducing a Tethered Dimer into Small Maf-Deficient Cells.
    Katsuoka F; Otsuki A; Takahashi M; Ito S; Yamamoto M
    Mol Cell Biol; 2019 Oct; 39(20):. PubMed ID: 31383749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein.
    Qian Z; Brunovskis P; Lee L; Vogt PK; Kung HJ
    J Virol; 1996 Oct; 70(10):7161-70. PubMed ID: 8794363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex.
    Ellenberger TE; Brandl CJ; Struhl K; Harrison SC
    Cell; 1992 Dec; 71(7):1223-37. PubMed ID: 1473154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A set of Hox proteins interact with the Maf oncoprotein to inhibit its DNA binding, transactivation, and transforming activities.
    Kataoka K; Yoshitomo-Nakagawa K; Shioda S; Nishizawa M
    J Biol Chem; 2001 Jan; 276(1):819-26. PubMed ID: 11036080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promoter of mouse transcription repressor bach1 is regulated by Sp1 and trans-activated by Bach1.
    Sun J; Muto A; Hoshino H; Kobayashi A; Nishimura S; Yamamoto M; Hayashi N; Ito E; Igarashi K
    J Biochem; 2001 Sep; 130(3):385-92. PubMed ID: 11530014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.